Lilly diabetes setbacks may spur shopping for Amylin
Eli Lilly and Co., under pressure to gain new products after setbacks this month with two diabetes drugs, may try to acquire its partner Amylin Pharmaceuticals Inc.
Health Care
Articles
Analysts: Lilly setbacks might spur shopping spree
CEO John Lechleiter claims Eli Lilly and Co. isn’t interested in big acquisitions to bolster its flagging drug pipeline, but its recently devalued partner Amylin Pharmaceuticals might be the right fit, industry analysts say.
Home Health Depot acquires Arcadia subsidiary
The division purchased by Home Health Depot markets and sells home health related items via mail and online. Terms of the deal were not disclosed.
UPDATE: Lilly, others see stock slide after drug rejection
Stock in Eli Lilly and Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. dropped after they were rebuffed a second time in a bid to gain U.S. approval of a once-weekly version of the diabetes drug Byetta.
FDA demands more tests on new Lilly diabetes drug
Eli Lilly and Co. will have to wait at least 18 months and conduct more studies before it wins market approval of a once-weekly version of diabetes drug Byetta, a potential billion-dollar drug.
Flood-damaged Columbus hospital reassessing expansion
Columbus Regional Hospital officials say a decline in its number of inpatients and an increase in outpatients have them considering whether to proceed with a planned $108 million expansion project.
City pitching in $38M for $192M Clarian project
The city is kicking in up to $38 million for infrastructure upgrades to support a massive expansion of the Clarian Health campus at 16th Street and Capitol Avenue.
Roche acquires assets from Virginia IT company
Terms of the deal, announced on Wednesday, call for Roche to acquire all the assets associated with Medical Automation Systems Inc.’s point-of-care information technology connectivity system.
WellPoint, Aetna led U.S. insurers in coverage denial
Until all consumers are required to buy health insurance, coverage restrictions are needed to keep people from gaming the system, insurers say.
Lilly falls short on ‘field goal’ attempt
Eli Lilly and Co.’s “miss” on a new use for its cancer drug Alimta was a rare failure to get an existing drug approved for a new use—even though the company has struggled mightily to get entirely new drugs to market.
Insurers cautious on accountable care
Health insurers, including locally based WellPoint Inc. and Advantage Health Solutions, have been looking to work with health care providers to form accountable-care organizations. But they also worry that the accountable-care concept will become nothing more than a negotiating tactic by hospitals and doctors.
My Health Care Manager wins $1.25M to improve software
The Indianapolis-based firm that helps seniors and their care givers navigate the health care system won a nearly $1.2 million grant from the National Institutes of Health.
Reform will boost health care costs, Indianapolis panel predicts
Rising costs aren't the only impact of reform, say panelists taking part in a Power Breakfast sponsored by Indianapolis Business Journal.
Lilly sues drug distributor over generic Zyprexa sales
Celesio’s Lloyds Pharmacy and Aah Pharmaceuticals businesses sold about 800,000 tablets of generic Zyprexa before agreeing in 2008 to halt sales, Lilly said in a complaint filed in the High Court in London.
Rehab hospital shakes up leadership
The CEO is on his way out and the board has been dissolved at Rehabilitation Hospital of Indiana, as its owners—Clarian Health and St. Vincent Health—work to pull the hospital closer to their own operations.
IU gets $4 million grant for new research center
IU will use its Lilly Endowment grant to open its news Center for Law, Ethics and Applied Research in Health Information.
Cook stent could prevent more amputations, study finds
A drug-coated stent from Indiana-based Cook Medical was more effective than standard therapy for patients with blockages in an upper-leg artery, a study found.
Columbus hospital suing FEMA for $17.1 million
Federal lawsuit, which stems from June 2008 flood that caused $167 million in damages and business income losses, alleges FEMA failed to pay the full amount the hospital is owed in federal funding.
Plastic surgery firm hit with surveillance litigation
Former employees say Meridian Plastic Surgery Center violated their rights when it secretly recorded them in various states of undress.
Health overhaul’s $264M question weighs down WellPoint
The failure by state regulators to decide how much insurers must spend on patient care is scaring investors from health-plan stocks and complicating insurance company decisions.